US20060217756A1 - Device and method of weight control via indirect abdominal cavity volume reduction - Google Patents
Device and method of weight control via indirect abdominal cavity volume reduction Download PDFInfo
- Publication number
- US20060217756A1 US20060217756A1 US11/091,127 US9112705A US2006217756A1 US 20060217756 A1 US20060217756 A1 US 20060217756A1 US 9112705 A US9112705 A US 9112705A US 2006217756 A1 US2006217756 A1 US 2006217756A1
- Authority
- US
- United States
- Prior art keywords
- hollow member
- abdominal cavity
- expansion
- implantable device
- surgical method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
Definitions
- This invention relates to weight control, and more particularly to a device and method for controlling body weight via indirect reduction of the volume of the abdominal cavity.
- Obesity is a chronic disease and constitutes a major health concern. In the United States alone obesity accounts for more than $100 billion in health care annually. Far from being a purely cosmetic issue, being obese or morbidly obese puts a person at an increased risk for developing and/or aggravating dozens of serious medical conditions. More than 30 obesity-related medical conditions are currently recognized. These include arthritis, several forms of cancer, carpal tunnel syndrome, cardiovascular disease, gallbladder disease, gout, hypertension, infertility, liver disease, low back pain, obstetric and gynecologic complications, sleep apnea, stroke, type-2 diabetes, and urinary stress incontinence.
- Obesity is commonly measured by using the Body Mass Index (BMI).
- BMI Body Mass Index
- obesity is defined as having a BMI of 30 kg/m 2 .
- Morbid obesity is defined as the condition of obesity coupled with one or more secondary debilitating factors, such as hypertension, cardiovascular disease and/or diabetes.
- a BMI of 40 kg/m 2 is generally recognized to constitute morbid obesity.
- morbid obesity ranks second only to smoking as a preventable cause of death in the U.S.
- obesity is recognized to be simply an imbalance between caloric intake and caloric burn rate, the factors producing obesity are varied and complex. Genetic, biological and even psychological influences can influence the condition. As a result, obesity is a disease that eludes simple treatment or attempts to shed weight.
- Weight loss is generally recommended for persons with obesity or morbid obesity.
- the loss of excess weight can improve the health of a person by lowering risks from obesity-related medical conditions.
- Methods of weight loss include dietary therapy, increased physical activity, behavior therapy, drug therapy, surgery or a combination of therapies.
- One general category of obesity surgery targets the relative absorption of food. This type of procedure seeks to shorten the length of, or otherwise modify, the small intestine to limit the amount of foods that is ultimately absorbed by the body (malabsorption).
- malabsorption procedures include: gastric bypass (e.g., Roux-en-Y gastric bypass); biliopancreatic diversion; and intestinal bypass.
- tissue expanders have been employed in the context of cosmetic and reconstructive surgery where the need for additional tissue is present.
- Tissue expanders are implantable devices capable of expansion over time. They take advantage of the fact that tissue under prolonged physical stress will produce additional tissue. Such devices are used to dissect tissue, create cavities or pockets, or separate layers of soft tissue.
- tissue dissection for example, a surgeon makes a remote incision into the body and inserts a hollow tissue expander into the incision to a point where a space or cavity or pocket is desired. Fluid is then forced into the expander to cause it to expand and separate two layers of tissue to form the desired space or cavity or pocket. The dissection takes place along the edges of the incision and peripherally outward from the tissue expander.
- tissue expanders Although there have been many improvements in tissue expanders since their inception, use of tissue expanders to date has been limited to dissecting tissue, creating cavities or pockets, or separating layers of soft tissue, and the like.
- the present invention comprises a device and method for controlling body weight via indirect reduction of the volume of the abdominal cavity utilizing a specialized tissue expander.
- One embodiment of the present invention includes a device for producing intra-abdominal pressure from a point superficial to the fascia of the abdominal cavity to decrease the volume of the abdomen without physically invading the abdominal cavity.
- an incision is made in the abdominal region of the body.
- an expandable device is placed into the incision to a point superficial to the fascia of the abdominal region.
- the device is expanded to produce intra-abdominal pressure, effectively reducing the volume of the abdominal cavity.
- intra-abdominal pressure is created without physical invasion of the abdominal cavity.
- An embodiment of the device of the present invention is an expandable hollow member including means for expansion.
- the hollow member includes both a rigid and a flexible region along its exterior surface. This feature, when the hollow member is oriented properly and expanded via the means for expansion, will direct the pressure created by the expansion of the hollow member towards the abdominal cavity. Such pressure will effectively reduce the volume of the abdominal cavity, causing the person to require less food to achieve a sense of satiety. The ingestion of less food by the person will also necessarily advantageously affect relative food absorption in the lower intestine.
- the level of expansion of the device (hollow member) of the present invention can be selectively adjusted via the means for expansion without the need for additional surgery. If, for example, weight loss is occurring too rapidly for the person, the expansion can be reduced. The effect of the reduction of expansion will be a reduction of intra-abdominal pressure created by same, allowing the person to ingest a higher volume of food. If, on the other hand, weight loss is not progressing or has reached a plateau, expansion of the device can be increased, thereby increasing the intra-abdominal pressure created and reducing the volume of food needed by the person to feel “full.”
- FIG. 1 is a cross section of an abdominal cavity of a human illustrating normal anatomy of same
- FIG. 2 is a cross section of an abdominal cavity of a human showing normal anatomy and including an embodiment of the system of the present invention (non-expanded);
- FIG. 3 is a flow chart outlining the steps of an embodiment of the method of the present invention.
- FIG. 4 is a cross section of an abdominal cavity of a human showing normal anatomy and including an embodiment of the system of the present invention with the system (expanded).
- FIG. 1 a cross section of an abdominal cavity of a human exhibiting normal anatomy, illustrates a body 10 , said body including an abdominal region 20 having skin 30 , fat 40 , muscle 50 , fascia 60 , a peritoneum 70 and an abdominal cavity 80 .
- the abdominal cavity 80 comprises the stomach (not shown) which receives and processes food and other nourishment for the body 10 , passing same to the intestines (not shown) of the body 10 .
- FIG. 2 illustrates a cross sectional view of the abdominal region 20 of the body 10 including placement of an embodiment of an implantable food restriction device 90 of the present invention (in non-expanded mode).
- the implantable food restriction device 90 is preferably comprised of a hollow member 92 and means for expansion and contraction (not shown) of the hollow member 92 .
- the hollow member 92 preferably includes a relatively non-expandable portion 100 and a relatively expandable portion 110 .
- the relatively expandable portion 110 is oriented towards the abdominal cavity 80 , thereby positioning the relatively non-expandable portion 100 of the hollow member 92 away from the abdominal cavity 80 (i.e., towards the fat 40 ).
- the hollow member 92 of the implantable food restriction device 90 of this embodiment is described as having a relatively expandable portion 110 and a relatively non-expandable portion 100 , it is noted that the implantable food restriction device 90 can utilize a hollow member 92 lacking the relatively expandable portion 110 and/or the relatively non-expandable portion 100 . Any expansion of the implantable food restriction device 90 will create intra-abdominal pressure that will reduce the relative volume of the abdominal cavity 80 . Therefore, any suitable design of the implantable food restriction device 90 is contemplated by this invention.
- the implantable food restriction device 90 includes means for expansion and contraction (not shown).
- Such means for expansion and contraction can be any suitable means for providing and extracting a liquid or gas from the hollow member in a manner that does not require additional surgical procedures.
- one such means is a tube that is relatively hollow and flexible and which protrudes from, or is contained within, the body when attached to the hollow member 92 of the implantable food restriction device 90 .
- the tube is utilized to provide and extract liquids or gases from the hollow member 92 . If a liquid or gas is provided to the hollow member 92 , it expands and creates the intra-abdominal pressure that reduces the relative volume of the abdominal cavity 80 .
- the intra-abdominal pressure created by the hollow member 92 of the implantable food restriction device 90 can be controlled over time by providing and/or extracting a liquid or gas from the hollow member 92 in response to weigh loss progress of the body 10 .
- a tube means has been described herein, it is noted that any suitable means for providing/extracting a liquid or gas from the hollow member 92 of the implantable food restriction device 90 may be employed with the present invention.
- the food restriction device 90 of the present invention can be constructed of any suitable material(s), and is preferably constructed of a durable, relatively flexible material or materials capable of being safe use for prolonged periods of time within the human body, such as surgical grade plastics, polymers and the like. Additionally, the hollow member 92 of the food restriction device 90 may be sized and shaped in any suitable combination to produce the desired level of intra-abdominal pressure necessary to achieve desired weight loss by the body 10 . It is noted that varying sizes, shapes and combinations thereof of the food restriction device 90 may be employed as suggested by the individual needs of the body 10 in question to optimize the results achieved via use of the present invention.
- one embodiment of the present invention surgical method for controlling weight of a body comprises five primary steps.
- an incision is made into the abdominal region of a body.
- the incision can be made utilizing any traditional means for same, including via scalpel, laser, or other suitable cutting device.
- an implantable food restriction device is provided, said implantable food restriction device having a hollow member and associated means for expansion and contraction.
- the hollow member of the implantable food restriction device is inserted in Step 320 into the incision created in step 300 .
- the food restriction device of the present invention may be inserted via any suitable method for same, including, without limitation, via endoscope or open method technique.
- the implantable food restriction device is positioned to a point superficial to the abdominal cavity.
- the hollow member of the implantable food restriction device is selectively expanded or contracted via the means for expansion and contraction over a time period to exert pressure on the abdominal cavity.
- the result of exerting pressure on the abdominal cavity is to control the relative volume of same.
- Increased pressure on the abdominal cavity will reduce its relative volume, causing the body (e.g., person) to require less food to achieve a sense of satiety.
- the ingestion of less food by the body will also necessarily advantageously affect relative food absorption in the lower intestine.
- the hollow member of the implantable food restriction device can be expanded or contracted without the need for additional surgery, allowing for highly flexible control over weight gain for the body. If, for example, weight loss is occurring too rapidly for the body, the expansion can be reduced.
- the effect of the reduction of expansion will be a reduction of intra-abdominal pressure created by same, allowing the person to ingest a higher volume of food (and also adjusting the relative food absorption rate in the lower intestine). The overall result will be a slow down in weight loss experienced by the body.
- FIG. 4 is an illustration of layers the abdominal region 20 of a body 10 including placement of an embodiment of the food restriction device 90 of the present invention (in expanded mode).
- the relatively expandable portion 110 of the hollow member 92 expands and directs the intra-abdominal pressure created by expansion of the food restriction device 90 towards the muscle 50 and the fascia 60 of the abdominal cavity 20 , which in turn apply pressure to the peritoneum 70 and, ultimately, the abdominal cavity 80 , the overall effect of which is to reduce the relative volume of the abdominal cavity 80 without the need for physical invasion of the abdominal cavity 80 .
- the body 10 With the relative volume of the abdominal cavity 80 reduced, the body 10 will require less food to achieve a sense of satiety. Additionally, the ingestion of less food by the body 10 will also necessarily advantageously affect relative food absorption in the lower intestine. The combined effect of the foregoing will be a reduction in weight of the body 10 .
- the food restriction device 90 is positioned to a point superficial to the abdominal cavity 80 .
- the food restriction device 90 is positioned to a point superficial to the fascia 60 of the abdominal region 20 .
- This positioning of the food restriction device 90 is considered an optimal balance of the desired transfer of intra-abdominal pressure to the abdominal cavity 80 with the desire to have the least physical invasion of the abdominal region 20 .
- optimal positioning of the food restriction device 90 is described as being superficial to the fascia 60 of the abdominal region 20 , it is noted that the invention contemplates positioning of the food restriction device 90 at any point within the abdominal region 20 that reduces the relative volume of the abdominal cavity 80 via the production of intra-abdominal pressure without physical invasion of the abdominal cavity 80 .
- the change in relative volume of the abdominal cavity 80 created as a result of the food restriction device 90 of the present invention is directly related to the relative change in volume of the hollow member 92 of the food restriction device 90 . Therefore, if additional weight loss by the body 10 is desired, the relative volume of the hollow member 92 of the food restriction device 90 can be increased via the means for expansion and contraction. Conversely, if it is desired that the body 10 experience less weight loss (or have the rate of weight reduction slowed), the relative volume of the hollow member 92 of the food restriction device 90 can be reduced via the means for contraction and expansion.
- One significant advantage of the device and method of the present invention is that it does not invade the abdominal cavity 80 .
- the lack of physical invasion of the abdominal cavity 80 eliminates leaking of stomach juices into the abdomen, injury to internal organs (e.g., spleen) and further avoids complications associated with the use of devices within the abdominal cavity 20 such as staples, bands and the like, thus leading to quicker recovery times, reduced hospital stays and increased patient satisfaction.
Abstract
A device for controlling the weight of a body comprises a hollow member having an expandable and a non-expandable portion to its exterior surface. The hollow member is selectively expanded and/or contracted following implantation in the abdominal cavity to direct pressure to the abdominal cavity, thereby restricting food intake without physically invading the abdominal cavity. The hollow member is preferably positioned superficial to the fascia, muscle, peritoneum and abdominal cavity of the abdominal region according to the method of the present invention to minimize the risks associated with traditional food intake restriction surgeries.
Description
- This invention relates to weight control, and more particularly to a device and method for controlling body weight via indirect reduction of the volume of the abdominal cavity.
- Obesity is a chronic disease and constitutes a major health concern. In the United States alone obesity accounts for more than $100 billion in health care annually. Far from being a purely cosmetic issue, being obese or morbidly obese puts a person at an increased risk for developing and/or aggravating dozens of serious medical conditions. More than 30 obesity-related medical conditions are currently recognized. These include arthritis, several forms of cancer, carpal tunnel syndrome, cardiovascular disease, gallbladder disease, gout, hypertension, infertility, liver disease, low back pain, obstetric and gynecologic complications, sleep apnea, stroke, type-2 diabetes, and urinary stress incontinence.
- Obesity is commonly measured by using the Body Mass Index (BMI). In terms of BMI, obesity is defined as having a BMI of 30 kg/m2. Morbid obesity is defined as the condition of obesity coupled with one or more secondary debilitating factors, such as hypertension, cardiovascular disease and/or diabetes. A BMI of 40 kg/m2 is generally recognized to constitute morbid obesity. Importantly, morbid obesity ranks second only to smoking as a preventable cause of death in the U.S.
- While obesity is recognized to be simply an imbalance between caloric intake and caloric burn rate, the factors producing obesity are varied and complex. Genetic, biological and even psychological influences can influence the condition. As a result, obesity is a disease that eludes simple treatment or attempts to shed weight.
- Weight loss is generally recommended for persons with obesity or morbid obesity. The loss of excess weight can improve the health of a person by lowering risks from obesity-related medical conditions. Methods of weight loss include dietary therapy, increased physical activity, behavior therapy, drug therapy, surgery or a combination of therapies.
- Attempts at sustained weight loss via non-surgical means within the population of the obese are overwhelmingly unsuccessful. Moreover, it is estimated that this disease has a recurrence rate in greater than 90%. Consequently, long-term results of conservative treatments for obesity are generally unsuccessful, and can actually prove detrimental by producing further loss of self-esteem with the regaining of weight.
- In contrast, surgery is a well-established method of long-term weight control for persons with obesity. Surgical procedures assist a person in losing weight by adjusting the way the body digests and/or absorbs calories. This is most often accomplished via surgically-implemented changes to the stomach and/or small intestine.
- One general category of obesity surgery targets the relative absorption of food. This type of procedure seeks to shorten the length of, or otherwise modify, the small intestine to limit the amount of foods that is ultimately absorbed by the body (malabsorption). Common examples of malabsorption procedures include: gastric bypass (e.g., Roux-en-Y gastric bypass); biliopancreatic diversion; and intestinal bypass.
- Other surgical methods address obesity via restriction of food intake. This type of surgical procedure seeks to alter the size (volume) of the stomach, therefore limiting the amount of food it can hold. The result is a premature feeling of satiety and a reduced intake of calories. Common examples of procedures producing food intake restriction include: vertical banded gastroplasty; gastric banding; and laparoscopic gastric banding.
- Through malabsorption, food intake restriction, or some combination of both, weight is reduced since less food either enters the stomach and/or less food remains in the small intestine long enough to be digested and absorbed.
- As with any surgical procedure, there are risks associated with obesity surgical procedures. Additionally, each procedure has an associated success rate that, to a certain extent, is dependent upon whether a person is willing to make certain lifestyle changes in association therewith. As a general rule, procedures that invasively alter the size or volume of the stomach carry with them increased risks, such as infections, leaking of stomach juices into the abdomen, injury to the spleen, band slippage, erosion of the band, breakdown of the staple line, and stomach pouch stretching from overeating. Such risks are due not only to the physical stapling, banding or other direct manipulation of the stomach, but also in part to the fact that the surgeon has to invade the skin, fat, fascia, muscle and peritoneum of the abdominal region to make physical contact with the abdominal cavity to conduct such procedures.
- In a previously unrelated area, tissue expanders have been employed in the context of cosmetic and reconstructive surgery where the need for additional tissue is present. Tissue expanders are implantable devices capable of expansion over time. They take advantage of the fact that tissue under prolonged physical stress will produce additional tissue. Such devices are used to dissect tissue, create cavities or pockets, or separate layers of soft tissue. In use for tissue dissection, for example, a surgeon makes a remote incision into the body and inserts a hollow tissue expander into the incision to a point where a space or cavity or pocket is desired. Fluid is then forced into the expander to cause it to expand and separate two layers of tissue to form the desired space or cavity or pocket. The dissection takes place along the edges of the incision and peripherally outward from the tissue expander.
- Although there have been many improvements in tissue expanders since their inception, use of tissue expanders to date has been limited to dissecting tissue, creating cavities or pockets, or separating layers of soft tissue, and the like.
- There remains a need for a device and method of addressing obesity that includes only minimally-invasive surgical procedures (thus avoiding many of the associated risks of surgical procedures that invasively alter the size of the stomach), but which produce success rates in terms of weight reduction and sustainability of same comparable to current, fully-invasive surgical procedures. Ideally, such a device and related method would reduce the volume of the abdominal cavity with a minimal amount of physical invasion of the abdominal cavity.
- The present invention comprises a device and method for controlling body weight via indirect reduction of the volume of the abdominal cavity utilizing a specialized tissue expander. One embodiment of the present invention includes a device for producing intra-abdominal pressure from a point superficial to the fascia of the abdominal cavity to decrease the volume of the abdomen without physically invading the abdominal cavity. In an embodiment of the method of the present invention, an incision is made in the abdominal region of the body. Next an expandable device is placed into the incision to a point superficial to the fascia of the abdominal region. Following placement, the device is expanded to produce intra-abdominal pressure, effectively reducing the volume of the abdominal cavity. Importantly, such intra-abdominal pressure is created without physical invasion of the abdominal cavity.
- An embodiment of the device of the present invention is an expandable hollow member including means for expansion. Optimally, the hollow member includes both a rigid and a flexible region along its exterior surface. This feature, when the hollow member is oriented properly and expanded via the means for expansion, will direct the pressure created by the expansion of the hollow member towards the abdominal cavity. Such pressure will effectively reduce the volume of the abdominal cavity, causing the person to require less food to achieve a sense of satiety. The ingestion of less food by the person will also necessarily advantageously affect relative food absorption in the lower intestine.
- Once in place using the present invention method, the level of expansion of the device (hollow member) of the present invention can be selectively adjusted via the means for expansion without the need for additional surgery. If, for example, weight loss is occurring too rapidly for the person, the expansion can be reduced. The effect of the reduction of expansion will be a reduction of intra-abdominal pressure created by same, allowing the person to ingest a higher volume of food. If, on the other hand, weight loss is not progressing or has reached a plateau, expansion of the device can be increased, thereby increasing the intra-abdominal pressure created and reducing the volume of food needed by the person to feel “full.”
- The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
-
FIG. 1 is a cross section of an abdominal cavity of a human illustrating normal anatomy of same; -
FIG. 2 is a cross section of an abdominal cavity of a human showing normal anatomy and including an embodiment of the system of the present invention (non-expanded); -
FIG. 3 is a flow chart outlining the steps of an embodiment of the method of the present invention; and -
FIG. 4 is a cross section of an abdominal cavity of a human showing normal anatomy and including an embodiment of the system of the present invention with the system (expanded). - Like reference symbols in the various drawings indicate like elements.
- The present invention comprises a device and method for controlling body weight via indirect reduction of the volume of the abdominal cavity utilizing a specialized tissue expander.
FIG. 1 , a cross section of an abdominal cavity of a human exhibiting normal anatomy, illustrates abody 10, said body including anabdominal region 20 havingskin 30,fat 40,muscle 50,fascia 60, aperitoneum 70 and anabdominal cavity 80. Theabdominal cavity 80 comprises the stomach (not shown) which receives and processes food and other nourishment for thebody 10, passing same to the intestines (not shown) of thebody 10. -
FIG. 2 illustrates a cross sectional view of theabdominal region 20 of thebody 10 including placement of an embodiment of an implantablefood restriction device 90 of the present invention (in non-expanded mode). The implantablefood restriction device 90 is preferably comprised of ahollow member 92 and means for expansion and contraction (not shown) of thehollow member 92. Thehollow member 92 preferably includes a relativelynon-expandable portion 100 and a relativelyexpandable portion 110. When placed in theabdominal region 20 of thebody 10, the relativelyexpandable portion 110 is oriented towards theabdominal cavity 80, thereby positioning the relativelynon-expandable portion 100 of thehollow member 92 away from the abdominal cavity 80 (i.e., towards the fat 40). Once placed within theabdominal region 20 and expanded (seeFIG. 4 ), thehollow member 92 will apply the force of pressure created from the expansion towards thefascia 60, themuscle 50, theperitoneum 70 and, ultimately, theabdominal cavity 80, thereby reducing the relative volume of theabdominal cavity 80. Although thehollow member 92 of the implantablefood restriction device 90 of this embodiment is described as having a relativelyexpandable portion 110 and a relativelynon-expandable portion 100, it is noted that the implantablefood restriction device 90 can utilize ahollow member 92 lacking the relativelyexpandable portion 110 and/or the relativelynon-expandable portion 100. Any expansion of the implantablefood restriction device 90 will create intra-abdominal pressure that will reduce the relative volume of theabdominal cavity 80. Therefore, any suitable design of the implantablefood restriction device 90 is contemplated by this invention. - The implantable
food restriction device 90 includes means for expansion and contraction (not shown). Such means for expansion and contraction can be any suitable means for providing and extracting a liquid or gas from the hollow member in a manner that does not require additional surgical procedures. For example, one such means is a tube that is relatively hollow and flexible and which protrudes from, or is contained within, the body when attached to thehollow member 92 of the implantablefood restriction device 90. The tube is utilized to provide and extract liquids or gases from thehollow member 92. If a liquid or gas is provided to thehollow member 92, it expands and creates the intra-abdominal pressure that reduces the relative volume of theabdominal cavity 80. The intra-abdominal pressure created by thehollow member 92 of the implantablefood restriction device 90 can be controlled over time by providing and/or extracting a liquid or gas from thehollow member 92 in response to weigh loss progress of thebody 10. Although a tube means has been described herein, it is noted that any suitable means for providing/extracting a liquid or gas from thehollow member 92 of the implantablefood restriction device 90 may be employed with the present invention. - The
food restriction device 90 of the present invention can be constructed of any suitable material(s), and is preferably constructed of a durable, relatively flexible material or materials capable of being safe use for prolonged periods of time within the human body, such as surgical grade plastics, polymers and the like. Additionally, thehollow member 92 of thefood restriction device 90 may be sized and shaped in any suitable combination to produce the desired level of intra-abdominal pressure necessary to achieve desired weight loss by thebody 10. It is noted that varying sizes, shapes and combinations thereof of thefood restriction device 90 may be employed as suggested by the individual needs of thebody 10 in question to optimize the results achieved via use of the present invention. - As illustrated in
FIG. 3 , one embodiment of the present invention surgical method for controlling weight of a body, said body including an abdominal region having skin, fat, muscle, fascia, a peritoneum and an abdominal cavity, comprises five primary steps. InStep 300 of the method, an incision is made into the abdominal region of a body. The incision can be made utilizing any traditional means for same, including via scalpel, laser, or other suitable cutting device. InStep 310, an implantable food restriction device is provided, said implantable food restriction device having a hollow member and associated means for expansion and contraction. The hollow member of the implantable food restriction device is inserted inStep 320 into the incision created instep 300. The food restriction device of the present invention may be inserted via any suitable method for same, including, without limitation, via endoscope or open method technique. InStep 330, the implantable food restriction device is positioned to a point superficial to the abdominal cavity. InStep 340 the hollow member of the implantable food restriction device is selectively expanded or contracted via the means for expansion and contraction over a time period to exert pressure on the abdominal cavity. The result of exerting pressure on the abdominal cavity is to control the relative volume of same. Increased pressure on the abdominal cavity will reduce its relative volume, causing the body (e.g., person) to require less food to achieve a sense of satiety. The ingestion of less food by the body will also necessarily advantageously affect relative food absorption in the lower intestine. Importantly, the hollow member of the implantable food restriction device can be expanded or contracted without the need for additional surgery, allowing for highly flexible control over weight gain for the body. If, for example, weight loss is occurring too rapidly for the body, the expansion can be reduced. The effect of the reduction of expansion will be a reduction of intra-abdominal pressure created by same, allowing the person to ingest a higher volume of food (and also adjusting the relative food absorption rate in the lower intestine). The overall result will be a slow down in weight loss experienced by the body. If, on the other hand, weight loss is not progressing at a satisfactory rate (e.g., weight loss has reached a plateau), expansion of the device can be increased, thereby increasing the intra-abdominal pressure created, reducing the volume of food needed by the person to feel “full,” and advantageously affecting the relative food absorption rate in the lower intestine. -
FIG. 4 is an illustration of layers theabdominal region 20 of abody 10 including placement of an embodiment of thefood restriction device 90 of the present invention (in expanded mode). As thehollow member 92 of thefood restriction device 90 is expanded via the means for expansion and contraction (not shown), in a preferred embodiment the relativelyexpandable portion 110 of thehollow member 92 expands and directs the intra-abdominal pressure created by expansion of thefood restriction device 90 towards themuscle 50 and thefascia 60 of theabdominal cavity 20, which in turn apply pressure to theperitoneum 70 and, ultimately, theabdominal cavity 80, the overall effect of which is to reduce the relative volume of theabdominal cavity 80 without the need for physical invasion of theabdominal cavity 80. With the relative volume of theabdominal cavity 80 reduced, thebody 10 will require less food to achieve a sense of satiety. Additionally, the ingestion of less food by thebody 10 will also necessarily advantageously affect relative food absorption in the lower intestine. The combined effect of the foregoing will be a reduction in weight of thebody 10. - In use, the
food restriction device 90 is positioned to a point superficial to theabdominal cavity 80. Specifically, in a preferred embodiment, thefood restriction device 90 is positioned to a point superficial to thefascia 60 of theabdominal region 20. This positioning of thefood restriction device 90 is considered an optimal balance of the desired transfer of intra-abdominal pressure to theabdominal cavity 80 with the desire to have the least physical invasion of theabdominal region 20. Although optimal positioning of thefood restriction device 90 is described as being superficial to thefascia 60 of theabdominal region 20, it is noted that the invention contemplates positioning of thefood restriction device 90 at any point within theabdominal region 20 that reduces the relative volume of theabdominal cavity 80 via the production of intra-abdominal pressure without physical invasion of theabdominal cavity 80. - As can be appreciated, the change in relative volume of the
abdominal cavity 80 created as a result of thefood restriction device 90 of the present invention is directly related to the relative change in volume of thehollow member 92 of thefood restriction device 90. Therefore, if additional weight loss by thebody 10 is desired, the relative volume of thehollow member 92 of thefood restriction device 90 can be increased via the means for expansion and contraction. Conversely, if it is desired that thebody 10 experience less weight loss (or have the rate of weight reduction slowed), the relative volume of thehollow member 92 of thefood restriction device 90 can be reduced via the means for contraction and expansion. - One significant advantage of the device and method of the present invention is that it does not invade the
abdominal cavity 80. The lack of physical invasion of theabdominal cavity 80 eliminates leaking of stomach juices into the abdomen, injury to internal organs (e.g., spleen) and further avoids complications associated with the use of devices within theabdominal cavity 20 such as staples, bands and the like, thus leading to quicker recovery times, reduced hospital stays and increased patient satisfaction. - A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. For example, the device could be shaped or otherwise modified (e.g., in size) so as to more completely focus the pressure created via expansion of same. Accordingly, other embodiments are within the scope of the following claims.
Claims (20)
1. An implantable device for use with a surgical method for controlling weight of a body, said implantable device comprising:
a hollow member;
said hollow member including an exterior surface having an expandable portion;
said exterior surface further including a non-expandable portion; and
means for expansion and contraction of the hollow member.
2. The implantable device of claim 1 , wherein the expandable portion and the non-expandable portion cover equal portions of the exterior surface of the hollow member.
3. The implantable device of claim 1 , wherein the expandable portion and the non-expandable portion cover unequal portions of the exterior surface of the hollow member.
4. The implantable device of claim 1 , wherein the hollow member is expanded and contracted from a point exterior to the body.
5. The implantable device of claim 1 , wherein the hollow member is expanded and contracted from a point interior to the body.
6. The implantable device of claim 1 , wherein the means for expansion and contraction includes means for introduction of a liquid or a gas to the hollow member to expand the hollow member.
7. The implantable device of claim 1 , wherein the means for expansion and contraction includes means for extraction of a liquid or a gas from the hollow member to contract the hollow member.
8. The implantable device of claim 6 , wherein the introduction of a fluid or a gas is accomplished via a hollow tube.
9. The implantable device of claim 7 , wherein the extraction of a fluid or a gas is accomplished via a hollow tube
10. The implantable device of claim 1 , wherein the expandable portion and the non-expandable portion are shaped to direct location of pressure created from expansion of the hollow member.
11. A surgical method for controlling weight of a body, said body including an abdominal region having skin, fat, muscle, fascia, a peritoneum and an abdominal cavity, the method comprising the steps of:
making an incision into the abdominal region of the body;
providing an implantable food restriction device having a hollow member and means for expansion and contraction;
inserting said hollow member into said incision;
positioning the hollow member to a point superficial to the abdominal cavity; and
expanding or contracting the hollow member via the means for expansion and contraction over a time period to exert pressure on the abdominal cavity.
12. The surgical method of claim 11 , wherein the step of positioning the hollow member includes locating the hollow member at a point deep to the skin and the fat of the abdominal region, but superficial to the fascia, the muscle and the peritoneum of the abdominal region.
13. The surgical method of claim 11 , wherein an exterior surface of the hollow member includes a non-expandable region and an expandable region.
14. The surgical method of claim 12 , wherein the step of positioning the hollow member further includes orienting the non-expandable region of the exterior surface of the hollow member superficial to the expandable region of the exterior surface of the hollow member such that pressure created from expansion and contraction of the hollow member is directed towards the abdominal cavity.
15. The surgical method of claim 11 , wherein the hollow member is expanded for a fixed period of time.
16. The surgical method of claim 11 , wherein the hollow member is expanded for an indefinite period of time.
17. The surgical method of claim 11 , wherein expansion and contraction of the hollow member is accomplished in response to weight loss by the body.
18. The surgical method of claim 11 , further including the step of removing the implantable food restriction device.
19. The surgical method of claim 11 , wherein endoscope or open technique is utilized to implant the food restriction device.
20. The surgical method of claim 11 , wherein the step of positioning the hollow member includes placing the hollow member at any point superficial to the abdominal cavity.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/091,127 US20060217756A1 (en) | 2005-03-28 | 2005-03-28 | Device and method of weight control via indirect abdominal cavity volume reduction |
US11/355,126 US20060217757A1 (en) | 2005-03-28 | 2006-02-15 | Device and method of weight control via indirect abdominal cavity volume reduction |
CNA2006800150021A CN101170972A (en) | 2005-03-28 | 2006-03-27 | Device and method of weight control via indirect abdominal cavity volume reduction |
CA002602421A CA2602421A1 (en) | 2005-03-28 | 2006-03-27 | Device and method of weight control via indirect abdominal cavity volume reduction |
PCT/US2006/011209 WO2006105053A2 (en) | 2005-03-28 | 2006-03-27 | Device and method of weight control via indirect abdominal cavity volume reduction |
JP2008504238A JP2008534138A (en) | 2005-03-28 | 2006-03-27 | Device and method for weight control via indirect abdominal volume reduction |
EP06739788A EP1863417A2 (en) | 2005-03-28 | 2006-03-27 | Device and method of weight control via indirect abdominal cavity volume reduction |
US11/759,833 US20070233169A1 (en) | 2005-03-28 | 2007-06-07 | Device and Method of Weight Control Via Indirect Abdominal Cavity Volume Reduction |
US12/466,928 US20090222032A1 (en) | 2005-03-28 | 2009-05-15 | Device and method of weight control via indirect abdominal cavity volume reduction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/091,127 US20060217756A1 (en) | 2005-03-28 | 2005-03-28 | Device and method of weight control via indirect abdominal cavity volume reduction |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/091,127 Continuation-In-Part US20060217756A1 (en) | 2005-03-28 | 2005-03-28 | Device and method of weight control via indirect abdominal cavity volume reduction |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/091,127 Continuation-In-Part US20060217756A1 (en) | 2005-03-28 | 2005-03-28 | Device and method of weight control via indirect abdominal cavity volume reduction |
US11/355,126 Continuation-In-Part US20060217757A1 (en) | 2005-03-28 | 2006-02-15 | Device and method of weight control via indirect abdominal cavity volume reduction |
US11/759,833 Division US20070233169A1 (en) | 2005-03-28 | 2007-06-07 | Device and Method of Weight Control Via Indirect Abdominal Cavity Volume Reduction |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060217756A1 true US20060217756A1 (en) | 2006-09-28 |
Family
ID=37036169
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/091,127 Abandoned US20060217756A1 (en) | 2005-03-28 | 2005-03-28 | Device and method of weight control via indirect abdominal cavity volume reduction |
US11/759,833 Abandoned US20070233169A1 (en) | 2005-03-28 | 2007-06-07 | Device and Method of Weight Control Via Indirect Abdominal Cavity Volume Reduction |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/759,833 Abandoned US20070233169A1 (en) | 2005-03-28 | 2007-06-07 | Device and Method of Weight Control Via Indirect Abdominal Cavity Volume Reduction |
Country Status (2)
Country | Link |
---|---|
US (2) | US20060217756A1 (en) |
CN (1) | CN101170972A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090222032A1 (en) * | 2005-03-28 | 2009-09-03 | Horndeski Gary M | Device and method of weight control via indirect abdominal cavity volume reduction |
US20060217757A1 (en) * | 2005-03-28 | 2006-09-28 | Horndeski Gary M | Device and method of weight control via indirect abdominal cavity volume reduction |
US20090177223A1 (en) * | 2008-01-03 | 2009-07-09 | Tara Chand Singhal | System and method for management of type 2 diabetes |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4592342A (en) * | 1983-05-02 | 1986-06-03 | Salmasian Samuel S | Method for appetite suppression and weight loss maintenance and device |
US4841948A (en) * | 1987-10-06 | 1989-06-27 | Mcghan Medical Corporation | Concave gase tissue expander |
US5630843A (en) * | 1994-06-30 | 1997-05-20 | Rosenberg; Paul H. | Double chamber tissue expander |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4246893A (en) * | 1978-07-05 | 1981-01-27 | Daniel Berson | Inflatable gastric device for treating obesity |
US6120437A (en) * | 1988-07-22 | 2000-09-19 | Inbae Yoon | Methods for creating spaces at obstructed sites endoscopically and methods therefor |
US5865728A (en) * | 1991-05-29 | 1999-02-02 | Origin Medsystems, Inc. | Method of using an endoscopic inflatable lifting apparatus to create an anatomic working space |
US6558400B2 (en) * | 2001-05-30 | 2003-05-06 | Satiety, Inc. | Obesity treatment tools and methods |
US20060217757A1 (en) * | 2005-03-28 | 2006-09-28 | Horndeski Gary M | Device and method of weight control via indirect abdominal cavity volume reduction |
-
2005
- 2005-03-28 US US11/091,127 patent/US20060217756A1/en not_active Abandoned
-
2006
- 2006-03-27 CN CNA2006800150021A patent/CN101170972A/en active Pending
-
2007
- 2007-06-07 US US11/759,833 patent/US20070233169A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4592342A (en) * | 1983-05-02 | 1986-06-03 | Salmasian Samuel S | Method for appetite suppression and weight loss maintenance and device |
US4841948A (en) * | 1987-10-06 | 1989-06-27 | Mcghan Medical Corporation | Concave gase tissue expander |
US5630843A (en) * | 1994-06-30 | 1997-05-20 | Rosenberg; Paul H. | Double chamber tissue expander |
Also Published As
Publication number | Publication date |
---|---|
US20070233169A1 (en) | 2007-10-04 |
CN101170972A (en) | 2008-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060217757A1 (en) | Device and method of weight control via indirect abdominal cavity volume reduction | |
O'Brien et al. | Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity | |
EP2370003B1 (en) | Gastric restriction devices for treating obesity | |
JP5068554B2 (en) | Gastric band introduction device | |
US20090216337A1 (en) | Gastric bypass prosthesis fixation system and method for treatment of obesity | |
US20050246037A1 (en) | Partial esophageal obstruction to limit food intake for treatment of obesity | |
US20100228349A1 (en) | Bulking of upper esophageal sphincter for treatment of obesity | |
WO2011149888A2 (en) | Methods and devices for regulating the activation of ghrelin hormones within a stomach | |
Miller et al. | Laparoscopic surgical concepts of morbid obesity | |
US20210298935A1 (en) | Gastric restriction devices for treating obesity | |
Miller | Obesity: surgical options | |
US20070233169A1 (en) | Device and Method of Weight Control Via Indirect Abdominal Cavity Volume Reduction | |
US20120316387A1 (en) | Adjustable gastric wrap (agw) | |
US20090222032A1 (en) | Device and method of weight control via indirect abdominal cavity volume reduction | |
US20170333049A1 (en) | Pyloric obstruction device with space-occupying device | |
US11642235B2 (en) | Gastric vest for restriction of the stomach to treat obesity | |
Sundbom et al. | Bariatric surgery | |
AU2014201234B2 (en) | Gastric restriction devices with fillable chambers and ablation means for treating obesity | |
WO2014014421A1 (en) | Device for external gastric restriction and tightening for prevention and treatment of obesity and diabetes | |
Kerrigan | Bariatric surgery | |
Ftmanekz et al. | Laparoscopic Vertical Banded Gastroplasty | |
WO2008068715A2 (en) | Gastric restrictive procedure for the treatment of obesity and associated co morbidities |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |